nstitute of Medical Biology (IMB), Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.
Institute for Research in Biomedicine, Università Della Svizzera Italiana , Bellinzona, Switzerland.
Cell Cycle. 2020 Dec;19(24):3508-3520. doi: 10.1080/15384101.2020.1850968. Epub 2020 Dec 11.
Aneuploidy is the condition of having an imbalanced karyotype, which is associated with tumor initiation, evolution, and acquisition of drug-resistant features, possibly by generating heterogeneous populations of cells with distinct genotypes and phenotypes. Multicellular eukaryotes have therefore evolved a range of extrinsic and cell-autonomous mechanisms for restraining proliferation of aneuploid cells, including activation of the tumor suppressor protein p53. However, accumulating evidence indicates that a subset of aneuploid cells can escape p53-mediated growth restriction and continue proliferating . Here we show that such aneuploid cell lines display a robust modal karyotype and low frequency of chromosomal aberrations despite ongoing chromosome instability. Indeed, while these aneuploid cells are able to survive for extended periods , their chromosomally unstable progeny remain subject to p53-induced senescence and growth restriction, leading to subsequent elimination from the aneuploid pool. This mechanism helps maintain low levels of heterogeneity in aneuploid populations and may prevent detrimental evolutionary processes such as cancer progression and development of drug resistance.
非整倍体是指染色体组不平衡的状态,与肿瘤的发生、发展以及获得耐药特性有关,可能是通过产生具有不同基因型和表型的异质细胞群体来实现的。因此,多细胞真核生物进化出了一系列外在的和细胞自主的机制来抑制非整倍体细胞的增殖,包括激活肿瘤抑制蛋白 p53。然而,越来越多的证据表明,一部分非整倍体细胞可以逃避 p53 介导的生长限制并继续增殖。在这里,我们发现尽管存在持续的染色体不稳定性,这些非整倍体细胞系仍表现出强大的模式染色体核型和低水平的染色体畸变。事实上,虽然这些非整倍体细胞能够长时间存活,但它们染色体不稳定的后代仍然受到 p53 诱导的衰老和生长限制的影响,从而导致随后从非整倍体池中被淘汰。这种机制有助于维持非整倍体群体中低水平的异质性,并可能防止有害的进化过程,如癌症进展和耐药性的发展。